NEOADJUVANT TREATMENT
Clinical trials for NEOADJUVANT TREATMENT explained in plain language.
Never miss a new study
Get alerted when new NEOADJUVANT TREATMENT trials appear
Sign up with your email to follow new studies for NEOADJUVANT TREATMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise in shrinking advanced thyroid tumors before surgery
Disease control Recruiting nowThis study tests a drug called zanzalintinib given before surgery for people with advanced thyroid cancer. The goal is to see if the drug can shrink tumors and make surgery more effective. About 45 adults with certain types of thyroid cancer will take part. Researchers will also …
Matched conditions: NEOADJUVANT TREATMENT
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:33 UTC
-
Feeding tube before cancer surgery may cut risks
Disease control Recruiting nowThis study looks at whether giving artificial nutrition through a feeding tube (jejunostomy) before surgery can lower the chance of complications after the operation. It includes 670 malnourished adults with esophageal or stomach cancer who are receiving pre-surgery treatment. Th…
Matched conditions: NEOADJUVANT TREATMENT
Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Promising drug cocktail aims to shrink esophageal tumors before surgery
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug adbelimumab to standard chemotherapy and the targeted drug apatinib can help shrink esophageal cancer before surgery. About 35 adults with resectable stage II–IVA esophageal squamous cell carcinoma will receive this combinati…
Matched conditions: NEOADJUVANT TREATMENT
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 13, 2026 16:03 UTC